Suspected Adverse Drug Reactions Associated With Leukotriene Receptor Antagonists Versus First Line Asthma Medications: A National Registry-Pharmacology Approach

Mohammed Khan; Christine Hirsch; Alan M Jones

Suspected Adverse Drug Reactions Associated With Leukotriene Receptor Antagonists Versus First Line Asthma Medications: A National Registry-Pharmacology Approach

Mohammed Khan, Christine Hirsch, Alan M Jones

Pharmacy

Research output: Working paper/Preprint › Preprint

Original language	English
Publisher	medRxiv
Publication status	Accepted/In press - Jun 2024

Cite this

@techreport{e7da4afd29344335a3c85c9a86babadf,

title = "Suspected Adverse Drug Reactions Associated With Leukotriene Receptor Antagonists Versus First Line Asthma Medications: A National Registry-Pharmacology Approach",

author = "Mohammed Khan and Christine Hirsch and Jones, {Alan M}",

year = "2024",

month = jun,

language = "English",

publisher = "medRxiv",

type = "WorkingPaper",

institution = "medRxiv",

}

TY - UNPB

T1 - Suspected Adverse Drug Reactions Associated With Leukotriene Receptor Antagonists Versus First Line Asthma Medications

T2 - A National Registry-Pharmacology Approach

AU - Khan, Mohammed

AU - Hirsch, Christine

AU - Jones, Alan M

PY - 2024/6

Y1 - 2024/6

UR - https://www.medrxiv.org/

UR - https://www.medrxiv.org/content/10.1101/2024.06.12.24308833v1.full.pdf

M3 - Preprint

BT - Suspected Adverse Drug Reactions Associated With Leukotriene Receptor Antagonists Versus First Line Asthma Medications

PB - medRxiv

ER -